Original paper
Progress on drug pricing negotiations in China
Abstract
On November 28th, 2019, the National Healthcare Security Administration (NHSA) and the Ministry of Human Resources and Social Security (MOHRSS) of China announced the results of drug pricing negotiations. Seventy first-negotiated drugs with 60.7% average price decrease and twenty-seven re-negotiated medicines with 26.4% average price fall, involving 11 disease categories, were successfully incorporated into National Reimbursement Drug List...
Paper Details
Title
Progress on drug pricing negotiations in China
Published Date
Dec 25, 2019
Journal
Volume
13
Issue
6
Pages
464 - 468